Sex differences in predicting dyslipidemia using polygenic risk score with fatty liver index and fibrotic nonalcoholic steatohepatitis index

Abstract Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are recognized risk factors for dyslipidemia. Current prediction models that rely solely on dyslipidemia polygenic risk score (PRS) have certain limitations. We aimed to validate simple indexes for NAFLD and...

Full description

Saved in:
Bibliographic Details
Main Authors: Sei Kim, Hae Young Yoo
Format: Article
Language:English
Published: Nature Portfolio 2025-03-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-92766-3
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849761815258464256
author Sei Kim
Hae Young Yoo
author_facet Sei Kim
Hae Young Yoo
author_sort Sei Kim
collection DOAJ
description Abstract Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are recognized risk factors for dyslipidemia. Current prediction models that rely solely on dyslipidemia polygenic risk score (PRS) have certain limitations. We aimed to validate simple indexes for NAFLD and NASH as predictors of dyslipidemia using the PRS. This study utilized cohort data from an urban population-based dataset comprising 48,263 South Koreans. The incidence of dyslipidemia was higher in men than in women (32.4% and 27.8%; p < 0.001). The PRS model predicted dyslipidemia more accurately in men (AUROC [95% confidence intervals]: 0.645 [0.636–0.754]). Notably, integrating the fatty liver index (FLI) and fibrotic NASH index (FNI) with the PRS model resulted in the highest accuracy in diagnosing dyslipidemia, particularly in men (AUROC [95% confidence intervals]: 0.704 [0.698–0.711]). In conclusion, a predictive model combining the PRS with FLI and FNI was validated. This model offers more accurate predictive value for diagnosing dyslipidemia, particularly in East Asian men. Thus, our study has the clinical potential for identifying high-risk individuals and determining preventive measures for dyslipidemia in a sex-specific manner.
format Article
id doaj-art-693774bf36a442ceb2aafbc6b3593559
institution DOAJ
issn 2045-2322
language English
publishDate 2025-03-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-693774bf36a442ceb2aafbc6b35935592025-08-20T03:05:53ZengNature PortfolioScientific Reports2045-23222025-03-011511710.1038/s41598-025-92766-3Sex differences in predicting dyslipidemia using polygenic risk score with fatty liver index and fibrotic nonalcoholic steatohepatitis indexSei Kim0Hae Young Yoo1Department of Nursing, Chung-Ang UniversityDepartment of Nursing, Chung-Ang UniversityAbstract Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are recognized risk factors for dyslipidemia. Current prediction models that rely solely on dyslipidemia polygenic risk score (PRS) have certain limitations. We aimed to validate simple indexes for NAFLD and NASH as predictors of dyslipidemia using the PRS. This study utilized cohort data from an urban population-based dataset comprising 48,263 South Koreans. The incidence of dyslipidemia was higher in men than in women (32.4% and 27.8%; p < 0.001). The PRS model predicted dyslipidemia more accurately in men (AUROC [95% confidence intervals]: 0.645 [0.636–0.754]). Notably, integrating the fatty liver index (FLI) and fibrotic NASH index (FNI) with the PRS model resulted in the highest accuracy in diagnosing dyslipidemia, particularly in men (AUROC [95% confidence intervals]: 0.704 [0.698–0.711]). In conclusion, a predictive model combining the PRS with FLI and FNI was validated. This model offers more accurate predictive value for diagnosing dyslipidemia, particularly in East Asian men. Thus, our study has the clinical potential for identifying high-risk individuals and determining preventive measures for dyslipidemia in a sex-specific manner.https://doi.org/10.1038/s41598-025-92766-3DyslipidemiaCoronary artery diseasePolygenic risk scoreNon-alcoholic fatty liver diseaseSteatohepatitis
spellingShingle Sei Kim
Hae Young Yoo
Sex differences in predicting dyslipidemia using polygenic risk score with fatty liver index and fibrotic nonalcoholic steatohepatitis index
Scientific Reports
Dyslipidemia
Coronary artery disease
Polygenic risk score
Non-alcoholic fatty liver disease
Steatohepatitis
title Sex differences in predicting dyslipidemia using polygenic risk score with fatty liver index and fibrotic nonalcoholic steatohepatitis index
title_full Sex differences in predicting dyslipidemia using polygenic risk score with fatty liver index and fibrotic nonalcoholic steatohepatitis index
title_fullStr Sex differences in predicting dyslipidemia using polygenic risk score with fatty liver index and fibrotic nonalcoholic steatohepatitis index
title_full_unstemmed Sex differences in predicting dyslipidemia using polygenic risk score with fatty liver index and fibrotic nonalcoholic steatohepatitis index
title_short Sex differences in predicting dyslipidemia using polygenic risk score with fatty liver index and fibrotic nonalcoholic steatohepatitis index
title_sort sex differences in predicting dyslipidemia using polygenic risk score with fatty liver index and fibrotic nonalcoholic steatohepatitis index
topic Dyslipidemia
Coronary artery disease
Polygenic risk score
Non-alcoholic fatty liver disease
Steatohepatitis
url https://doi.org/10.1038/s41598-025-92766-3
work_keys_str_mv AT seikim sexdifferencesinpredictingdyslipidemiausingpolygenicriskscorewithfattyliverindexandfibroticnonalcoholicsteatohepatitisindex
AT haeyoungyoo sexdifferencesinpredictingdyslipidemiausingpolygenicriskscorewithfattyliverindexandfibroticnonalcoholicsteatohepatitisindex